Copyright Reports & Markets. All rights reserved.

Global Pharmacogenomics Services Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Pharmacogenomics Services Market Status and Forecast (2017-2028)
      • 1.3.2 Global Pharmacogenomics Services Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Pharmacogenomics Services Supply by Company

    • 2.1 Global Pharmacogenomics Services Sales Value by Company
    • 2.2 Pharmacogenomics Services Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Pharmacogenomics Services Market Status by Type

    • 3.1 Pharmacogenomics Services Type Introduction
      • 3.1.1 Genotyping
      • 3.1.2 SNP Identification
      • 3.1.3 Pharmacogenetic Testing
      • 3.1.4 Others
    • 3.2 Global Pharmacogenomics Services Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Pharmacogenomics Services Market Status by Application

    • 4.1 Pharmacogenomics Services Segment by Application
      • 4.1.1 Oncology
      • 4.1.2 Infectious Diseases
      • 4.1.3 Psychiatry
      • 4.1.4 Cardiovascular
      • 4.1.5 Others
    • 4.2 Global Pharmacogenomics Services Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Pharmacogenomics Services Market Status by Region

    • 5.1 Global Pharmacogenomics Services Market by Region
    • 5.2 North America Pharmacogenomics Services Market Status
    • 5.3 Europe Pharmacogenomics Services Market Status
    • 5.4 Asia Pacific Pharmacogenomics Services Market Status
    • 5.5 Central & South America Pharmacogenomics Services Market Status
    • 5.6 Middle East & Africa Pharmacogenomics Services Market Status

    6 North America Pharmacogenomics Services Market Status

    • 6.1 North America Pharmacogenomics Services Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Pharmacogenomics Services Market Status

    • 7.1 Europe Pharmacogenomics Services Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Pharmacogenomics Services Market Status

    • 8.1 Asia Pacific Pharmacogenomics Services Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Pharmacogenomics Services Market Status

    • 9.1 Central & South America Pharmacogenomics Services Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Pharmacogenomics Services Market Status

    • 10.1 Middle East & Africa Pharmacogenomics Services Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Pharmacogenomics Services Market Forecast by Type and by Application

    • 12.1 Global Pharmacogenomics Services Sales Value Forecast (2023-2028)
    • 12.2 Global Pharmacogenomics Services Forecast by Type
    • 12.3 Global Pharmacogenomics Services Forecast by Application

    13 Global Pharmacogenomics Services Market Forecast by Region/Country

    • 13.1 Global Pharmacogenomics Services Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Thermo Fisher Scientific Inc.
      • 14.1.1 Company Information
      • 14.1.2 Pharmacogenomics Services Product Introduction
      • 14.1.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Quest Diagnostics Incorporated
      • 14.2.1 Company Information
      • 14.2.2 Pharmacogenomics Services Product Introduction
      • 14.2.3 Quest Diagnostics Incorporated Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 QIAGEN N.V.
      • 14.3.1 Company Information
      • 14.3.2 Pharmacogenomics Services Product Introduction
      • 14.3.3 QIAGEN N.V. Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Precipio
      • 14.4.1 Company Information
      • 14.4.2 Pharmacogenomics Services Product Introduction
      • 14.4.3 Precipio Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 OPKO Health
      • 14.5.1 Company Information
      • 14.5.2 Pharmacogenomics Services Product Introduction
      • 14.5.3 OPKO Health Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 OneOme, LLC
      • 14.6.1 Company Information
      • 14.6.2 Pharmacogenomics Services Product Introduction
      • 14.6.3 OneOme, LLC Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 OmeCare
      • 14.7.1 Company Information
      • 14.7.2 Pharmacogenomics Services Product Introduction
      • 14.7.3 OmeCare Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Myriad Genetics, Inc.
      • 14.8.1 Company Information
      • 14.8.2 Pharmacogenomics Services Product Introduction
      • 14.8.3 Myriad Genetics, Inc. Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Mesa Laboratories, Inc.
      • 14.9.1 Company Information
      • 14.9.2 Pharmacogenomics Services Product Introduction
      • 14.9.3 Mesa Laboratories, Inc. Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Laboratory Corporation of America Holdings
      • 14.10.1 Company Information
      • 14.10.2 Pharmacogenomics Services Product Introduction
      • 14.10.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Illumina, Inc.
    • 14.12 GeneOmbio Technologies Pvt Ltd.
    • 14.13 F. Hoffmann-La Roche Ltd.
    • 14.14 Exact Sciences Corporation
    • 14.15 Dynamic DNA Laboratories
    • 14.16 DiaCarta, Inc.
    • 14.17 Admera Health, LLC
    • 14.18 Abbott Laboratories
    • 14.19 23andMe, Inc.

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Pharmacogenomics Services market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Pharmacogenomics Services industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Pharmacogenomics Services market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Pharmacogenomics Services Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Pharmacogenomics Services market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Pharmacogenomics Services Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Pharmacogenomics Services industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Genotyping
      SNP Identification
      Pharmacogenetic Testing
      Others

      Segmented by Application
      Oncology
      Infectious Diseases
      Psychiatry
      Cardiovascular
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Thermo Fisher Scientific Inc.
      Quest Diagnostics Incorporated
      QIAGEN N.V.
      Precipio
      OPKO Health
      OneOme, LLC
      OmeCare
      Myriad Genetics, Inc.
      Mesa Laboratories, Inc.
      Laboratory Corporation of America Holdings
      Illumina, Inc.
      GeneOmbio Technologies Pvt Ltd.
      F. Hoffmann-La Roche Ltd.
      Exact Sciences Corporation
      Dynamic DNA Laboratories
      DiaCarta, Inc.
      Admera Health, LLC
      Abbott Laboratories
      23andMe, Inc.
      Buy now